- $1.05m
- $9.58m
- $4.35m
Brief: Nebula Genomics Strengthens Advisory Board With Appointment Of Russ Altman, M.D., Ph.D.
Brief: Prophase Labs - Co And CFO Bill White Agreed To White’s Voluntary Separation From Co
Prophase Labs Inc reports results for the quarter ended in June - Earnings Summary
Brief: ProPhase Labs Announces Record Second Quarter 2022 Financial Results
Prophase Labs Inc expected to post earnings of 18 cents a share - Earnings Preview
Brief: Prophase Labs Announces New $6 Million Stock Repurchase Plan
Document Security Solutions rises on licensing deal with ProPhase Labs
Brief: DSS Announces Licensing Of Impact Biomedical’s Linebacker Portfolio To Prophase Labs
Brief: Prophase Labs Announces Licensing Of New Investigational Cancer Compounds
Brief: Prophase Labs Announces Formation Of Prophase Biopharma Inc (PBIO) For The Licensing And Development Of Novel Drugs, Compounds And Biotechnology
Brief: Impact Biomedical Announces License Agreement With Prophase Labs To Produce And Distribute Viral-Fighting Compound Equivir
Brief: Prophase Labs Announces Significant Laboratory Expansion
Brief: ProPhase Labs Reports Q1 EPS $0.81
Prophase Labs Inc expected to post earnings of 39 cents a share - Earnings Preview
Brief: ProPhase Labs Announces Appointment Of Bill White As Chief Financial Officer
Prophase Labs Inc expected to post earnings of 39 cents a share - Earnings Preview
Brief: Prophase Labs Reports Q4 Revenue Of $45.2 Mln
Prophase Labs Inc expected to post earnings of 44 cents a share - Earnings Preview
Prophase Labs Inc expected to post earnings of 44 cents a share - Earnings Preview